S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
Log in

NASDAQ:BLBDBlue Bird Stock Price, Forecast & News

$12.30
+0.19 (+1.57 %)
(As of 08/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$12.03
Now: $12.30
$12.78
50-Day Range
$12.53
MA: $13.45
$14.99
52-Week Range
$8.40
Now: $12.30
$23.99
Volume179,487 shs
Average Volume138,125 shs
Market Capitalization$332.43 million
P/E Ratio13.09
Dividend YieldN/A
Beta1.34
Blue Bird Corporation designs, engineers, manufactures, and sells school buses and related parts in the United States, Canada, and internationally. It operates through two segments, Bus and Parts. The company offers Type C, Type D, and specialty buses; and alternative fuel applications through its propane-powered, gasoline-powered, compressed natural gas-powered, and electric powered school buses. It sells its products through a network of dealers, as well as directly to fleet operators, the United States government, and state governments; and a parts distribution center. The company was founded in 1927 and is headquartered in Macon, Georgia.
Read More
Blue Bird logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.81 out of 5 stars


Industry, Sector and Symbol

Industry Truck & bus bodies
Sub-IndustryN/A
Current SymbolNASDAQ:BLBD
CUSIPN/A
Phone478-822-2801

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.02 billion
Cash Flow$1.77 per share
Book Value($2.56) per share

Profitability

Net Income$24.30 million

Miscellaneous

Employees2,300
Market Cap$332.43 million
Next Earnings Date12/9/2020 (Estimated)
OptionableNot Optionable
$12.30
+0.19 (+1.57 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BLBD News and Ratings via Email

Sign-up to receive the latest news and ratings for BLBD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Blue Bird (NASDAQ:BLBD) Frequently Asked Questions

How has Blue Bird's stock price been impacted by COVID-19?

Blue Bird's stock was trading at $14.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BLBD stock has decreased by 17.2% and is now trading at $12.30.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Blue Bird?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Blue Bird in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Blue Bird
.

When is Blue Bird's next earnings date?

Blue Bird is scheduled to release its next quarterly earnings announcement on Wednesday, December 9th 2020.
View our earnings forecast for Blue Bird
.

How were Blue Bird's earnings last quarter?

Blue Bird Corp (NASDAQ:BLBD) released its quarterly earnings results on Wednesday, August, 12th. The company reported $0.16 EPS for the quarter, beating the consensus estimate of $0.12 by $0.04. Blue Bird had a net margin of 2.37% and a negative return on equity of 61.92%.
View Blue Bird's earnings history
.

What price target have analysts set for BLBD?

2 Wall Street analysts have issued 12-month price objectives for Blue Bird's shares. Their forecasts range from $12.00 to $22.00. On average, they expect Blue Bird's share price to reach $17.00 in the next year. This suggests a possible upside of 38.2% from the stock's current price.
View analysts' price targets for Blue Bird
.

Has Blue Bird been receiving favorable news coverage?

News stories about BLBD stock have been trending somewhat negative this week, InfoTrie reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Blue Bird earned a media sentiment score of -1.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future.
View the latest news about Blue Bird
.

Are investors shorting Blue Bird?

Blue Bird saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 458,500 shares, an increase of 22.2% from the June 15th total of 375,300 shares. Based on an average daily trading volume, of 142,000 shares, the days-to-cover ratio is presently 3.2 days. Currently, 3.6% of the shares of the stock are short sold.
View Blue Bird's Short Interest
.

Who are some of Blue Bird's key competitors?

What other stocks do shareholders of Blue Bird own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Blue Bird investors own include NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Netflix (NFLX), AbbVie (ABBV), Canopy Growth (CGC), Activision Blizzard (ATVI), Gilead Sciences (GILD), Micron Technology (MU) and Roku (ROKU).

Who are Blue Bird's key executives?

Blue Bird's management team includes the following people:
  • Mr. Philip Horlock, Pres, CEO & Director (Age 63)
  • Mr. Phil Tighe, CFO & Chief Accounting Officer (Age 65)
  • Mr. Thomas Arthur Roberts, Chief Admin. Officer (Age 67)
  • Mr. Mark R. Benfield, Director of Investor Relations & Gov. Affairs
  • Mr. Paul Yousif, Gen. Counsel & Corp. Treasurer (Age 44)

What is Blue Bird's stock symbol?

Blue Bird trades on the NASDAQ under the ticker symbol "BLBD."

Who are Blue Bird's major shareholders?

Blue Bird's stock is owned by many different retail and institutional investors. Top institutional investors include William Blair Investment Management LLC (4.51%), Skandinaviska Enskilda Banken AB publ (3.40%), Blair William & Co. IL (0.99%), North Star Investment Management Corp. (0.98%), Epoch Investment Partners Inc. (0.73%) and Olstein Capital Management L.P. (0.50%). Company insiders that own Blue Bird stock include Asp Bb Holdings Llc, Daniel J Hennessy, Paul Yousif and Phil Horlock.
View institutional ownership trends for Blue Bird
.

Which major investors are selling Blue Bird stock?

BLBD stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, William Blair Investment Management LLC, Mackay Shields LLC, North Star Investment Management Corp., Skandinaviska Enskilda Banken AB publ , UBS Group AG, Goldman Sachs Group Inc., and Bank of America Corp DE. Company insiders that have sold Blue Bird company stock in the last year include Paul Yousif, and Phil Horlock.
View insider buying and selling activity for Blue Bird
.

Which major investors are buying Blue Bird stock?

BLBD stock was acquired by a variety of institutional investors in the last quarter, including Epoch Investment Partners Inc., Blair William & Co. IL, Baird Financial Group Inc., PDT Partners LLC, LSV Asset Management, Assenagon Asset Management S.A., Campbell & CO Investment Adviser LLC, and Trexquant Investment LP.
View insider buying and selling activity for Blue Bird
.

How do I buy shares of Blue Bird?

Shares of BLBD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Blue Bird's stock price today?

One share of BLBD stock can currently be purchased for approximately $12.30.

How big of a company is Blue Bird?

Blue Bird has a market capitalization of $332.43 million and generates $1.02 billion in revenue each year. The company earns $24.30 million in net income (profit) each year or $1.49 on an earnings per share basis. Blue Bird employs 2,300 workers across the globe.

What is Blue Bird's official website?

The official website for Blue Bird is www.blue-bird.com.

How can I contact Blue Bird?

Blue Bird's mailing address is 3920 Arkwright Road 2nd Floor, Macon GA, 31210. The company can be reached via phone at 478-822-2801 or via email at [email protected]

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.